GGrantIndex
← Leaderboards

Craig N Morrell

University Of Rochester

$13,426,108
Attributed
$17,751,796
Total exposure
12
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,751,796 · 12

By mechanism

R01$15,860,099 · 8
K08$572,180 · 1
T32$512,267 · 1
R21$423,500 · 1
R56$383,750 · 1

Top collaborators

Most similar at University Of Rochester

Same institution · by research overlap

Others in their field

Top investigators on “Mediating

Research focus

MediatingBlood PlateletsIn VivoIn VitroInflammatoryResponseThrombosisInflammationSignal TransductionTraffickingCellsComplexPlayMonocyteImmuneEndothelial CellsPathway InteractionsPlatelet ActivationPublishingImmune ResponseImmune SystemPhenotypeReceptorAffect

Grant awards (42)

Platelet Regulation of Monocyte Responses in Vascular Inflammation$573,261
R01 · FY2025 · HL · contact PI
Tissue Dependent Megakaryocyte Functions$509,139
R01 · FY2025 · HL · contact PI
Tissue Dependent Megakaryocyte Functions$498,957
R01 · FY2024 · HL · contact PI
IMSD at the University of Rochester$344,844
T32 · FY2024 · GM · contact PI
Tissue Dependent Megakaryocyte Functions$509,139
R01 · FY2023 · HL · contact PI
IMSD at the University of Rochester$167,423
T32 · FY2023 · GM · contact PI
Pathological flow-induced endothelial damage and plaque erosion$782,390
R01 · FY2022 · HL
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury$632,045
R01 · FY2022 · HL
Tissue Dependent Megakaryocyte Functions$509,139
R01 · FY2022 · HL · contact PI
Pathological flow-induced endothelial damage and plaque erosion$788,251
R01 · FY2021 · HL
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury$632,045
R01 · FY2021 · HL
Novel mechanisms of platelet modified monocyte phenotype$464,364
R01 · FY2021 · HL · contact PI
Novel mechanisms of platelet modified monocyte phenotype$364,506
R01 · FY2021 · HL · contact PI
Platelet-Regulated Immune Responses in Neonates Following Transfusion$192,500
R21 · FY2021 · HL
Pathological flow-induced endothelial damage and plaque erosion$793,939
R01 · FY2020 · HL
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury$632,045
R01 · FY2020 · HL
Novel mechanisms of platelet modified monocyte phenotype$464,364
R01 · FY2020 · HL · contact PI
Platelet-Regulated Immune Responses in Neonates Following Transfusion$231,000
R21 · FY2020 · HL
Pathological flow-induced endothelial damage and plaque erosion$829,206
R01 · FY2019 · HL
ERK5 and CD36 link oxidative stress to platelet dysfunction and ischemic injury$645,045
R01 · FY2019 · HL
Novel mechanisms of platelet modified monocyte phenotype$464,364
R01 · FY2019 · HL · contact PI
Novel mechanisms of platelet modified monocyte phenotype$464,364
R01 · FY2018 · HL · contact PI
Novel platelet functions for in T-cell helper cell responses$383,750
R01 · FY2018 · HL · contact PI
Novel platelet functions for in T-cell helper cell responses$383,750
R01 · FY2017 · HL · contact PI
Novel platelet functions for in T-cell helper cell responses$383,750
R01 · FY2016 · HL · contact PI
Novel platelet functions for in T-cell helper cell responses$383,750
R01 · FY2015 · HL · contact PI
VAMP8 regulates endothelial exocytosis and microvascular obstruction$383,750
R56 · FY2014 · HL
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate Receptor$382,388
R01 · FY2012 · HL · contact PI
The Role of Platelets in Alloantibody Mediated Transplant Rejection$382,388
R01 · FY2012 · HL · contact PI
The Role of Platelets in Alloantibody Mediated Transplant Rejection$386,250
R01 · FY2011 · HL · contact PI
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate Receptor$385,625
R01 · FY2011 · HL · contact PI
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate Receptor$382,916
R01 · FY2010 · HL · contact PI
The Role of Platelets in Alloantibody Mediated Transplant Rejection$382,813
R01 · FY2010 · HL · contact PI
Glutamate Mediates Platelet Activation through an Ionotropic Glutamate Receptor$410,000
R01 · FY2009 · HL · contact PI
The Role of Platelets in Alloantibody Mediated Transplant Rejection$384,791
R01 · FY2009 · HL · contact PI
The Role of Platelets in Alloantibody Mediated Transplant Rejection$261,365
R01 · FY2009 · HL · contact PI
The Role of Platelets in Alloantibody Mediated Transplant Rejection$410,000
R01 · FY2008 · HL · contact PI
Nitric Oxide Regulation of Platelet Granule Exocytosis$125,955
K08 · FY2008 · HL · contact PI
Nitric Oxide Regulation of Platelet Granule Exocytosis$123,072
K08 · FY2007 · HL · contact PI
Nitric Oxide Regulation of Platelet Granule Exocytosis$120,275
K08 · FY2006 · HL · contact PI
Nitric Oxide Regulation of Platelet Granule Exocytosis$117,558
K08 · FY2005 · HL
Nitric Oxide Regulation of Platelet Granule Exocytosis$85,320
K08 · FY2004 · HL